Literature DB >> 12856347

Adherence practices among people living with HIV.

B D Adam1, E Maticka-Tyndale, J J Cohen.   

Abstract

This paper offers a critique of patient-deficit models of adherence by examining the articulation of dosing schedules and food prohibitions with the structure of everyday lives. Interviews with 31 men and 4 women taking HAART show that doses associated with regular daily life events are most consistently taken, but many individuals rework official dosing guidelines around timing and food consumption. Barriers to adherence often arise from conflicting demands imposed by work schedules, different medications, food prohibitions, and even outright discrimination as in the case of US immigration policy. Adherence may be the outcome of compromises made in an effort to solve contradictory demands, and may be situational and related to the qualities of particular drugs, as much as to personality traits. Autobiographical narratives that give order to one's sense of self provide foundations upon which adherence decision making occurs. Finally, perceptions of drug effectiveness may lead to self-reinforcing adherence practices.

Entities:  

Mesh:

Year:  2003        PMID: 12856347     DOI: 10.1080/0954012031000068407

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  17 in total

1.  Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.

Authors:  S Kehlenbeck; U Betz; A Birkmann; B Fast; A H Göller; K Henninger; T Lowinger; D Marrero; A Paessens; D Paulsen; V Pevzner; R Schohe-Loop; H Tsujishita; R Welker; J Kreuter; H Rübsamen-Waigmann; F Dittmer
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  A Qualitative Study of Providers' Perception of Adherence of Women Living with HIV/AIDS in Puerto Rico.

Authors:  Marta Rivero-Méndez; Carol S Dawson-Rose; Solymar S Solís-Báez
Journal:  Qual Rep       Date:  2010-03-01

3.  Adherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India.

Authors:  Rajib Saha; Indranil Saha; Aditya Prasad Sarkar; Dilip Kumar Das; Raghunath Misra; Krishnadas Bhattacharya; Rabindra Nath Roy; Abantika Bhattacharya
Journal:  Singapore Med J       Date:  2014-02       Impact factor: 1.858

4.  "It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting.

Authors:  Melissa H Watt; Suzanne Maman; Jo Anne Earp; Eugenia Eng; Philip W Setel; Carol E Golin; Mark Jacobson
Journal:  Soc Sci Med       Date:  2009-03-28       Impact factor: 4.634

5.  Missed opportunities for religious organizations to support people living with HIV/AIDS: findings from Tanzania.

Authors:  Melissa H Watt; Suzanne Maman; Mark Jacobson; John Laiser; Muze John
Journal:  AIDS Patient Care STDS       Date:  2009-05       Impact factor: 5.078

Review 6.  Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.

Authors:  Edward J Mills; Jean B Nachega; David R Bangsberg; Sonal Singh; Beth Rachlis; Ping Wu; Kumanan Wilson; Iain Buchan; Christopher J Gill; Curtis Cooper
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

7.  Predictors of Loss to follow-up in Patients Living with HIV/AIDS after Initiation of Antiretroviral Therapy.

Authors:  Tezera Moshago Berheto; Demissew Berihun Haile; Salahuddin Mohammed
Journal:  N Am J Med Sci       Date:  2014-09

Review 8.  Pharmaceutical HIV prevention technologies in the UK: six domains for social science research.

Authors:  Peter Keogh; Catherine Dodds
Journal:  AIDS Care       Date:  2015-01-03

9.  Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.

Authors:  Sharada P Wasti; Padam Simkhada; Julian Randall; Jennifer V Freeman; Edwin van Teijlingen
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

10.  Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia.

Authors:  Alemayehu Amberbir; Kifle Woldemichael; Sofonias Getachew; Belaineh Girma; Kebede Deribe
Journal:  BMC Public Health       Date:  2008-07-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.